A nationwide shortage of cancer drugs is forcing some physicians to either ration the chemotherapy drugs or try other medications. Dr. Amelia Jernigan with LSU Health New Orleans Gynecologic Oncology said they’ve noticed the shortage and they are substituting other meds when possible.
“Or do things like decrease the dose that they’re using or increase the interval in between chemotherapy treatments. But I think we’re all a little concerned that we might be providing inferior care by rationing,” said Jernigan.
Among the medications are carboplatin and cisplatin which are used as a first-line chemo treatment for a variety of cancers. Jernigan said they are tried-and-true drugs that are generic and cost less than newer medications and that’s part of the problem.
“And what happens is there’s just not a big enough incentive for drug companies and manufacturing companies to come up back-up plans because the profit margin is just so narrow,” said Jernigan.
Physicians and their staff are forced to file for Prior Authorizations with insurance carriers when they have to choose a non-generic alternative. Jernigan said it’s a lot of paperwork and the process can be lengthy. She has a suggestion if you or a family member are impacted by the shortages.
“Write their lawmakers and urge them to work with the FDA to ensure this type of thing doesn’t happen again in the future,” said Jernigan.
Jernigan said some treatment centers are having to choose between patients who can be cured with chemotherapy versus those who are on chemo for palliative care.
Comments